The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Abstract
In a double blind, cross-over placebo-controlled trial, we studied the effects of 26 weeks of replacement therapy with recombinant human GH on body composition, metabolic parameters, and well-being in 10 patients with adult-onset GH deficiency (GHD). All patients received appropriate thyroid, adrenal, and gonadal replacement therapy. The dose of recombinant human GH was 0.25-0.5 U/kg.week (0.013-0.026 mg/kg.day) and was administered sc daily at bedtime. One patient was withdrawn from the study because of edema and atrial fibrillation. Body composition was estimated with three independent methods: computed tomography, bioelectric impedance, and total body potassium combined with total body water assessments. The Comprehensive Psychological Rating Scale and the Symptom Check List-90 were used to assess any change in psychopathology. After 26 weeks of treatment, adipose tissue (AT) mass decreased 4.7 kg (P < 0.001). Subcutaneous AT decreased by an average of 13%, whereas visceral AT was reduced by 30%. Muscle volume increased by 2.5 kg (5%; P < 0.05). According to the four-compartment model derived from assessments of total body potassium and total body water, body cell mass and extracellular fluid volume increased significantly by 1.6 and 3.0 kg, whereas body fat decreased by 6.1 kg. Results obtained by the bioelectric impedance technique were similar. The mean (+/- SD) concentrations of insulin-like growth factor-I increased from 0.26 (0.06) at baseline to 2.56 (1.55) and 2.09 (1.03) kU/L after 6 and 26 weeks of treatment. Calcium and serum phosphate, osteocalcin, and procollagen-III concentrations were significantly higher, and intact PTH concentrations were reduced after 6 and 26 weeks of treatment, respectively. Total and free T3 concentrations were significantly increased after 6 and 26 weeks of treatment, whereas free T4 concentrations were reduced at 6 weeks, but after 26 weeks, free T4 concentrations had returned to pretreatment values. Finally, after 26 weeks of treatment, there was a decrease in the Comprehensive Psychological Rating Scale score (P < 0.05). The results show that GH replacement in GHD adults results in marked alterations in body composition, fat distribution, and bone and mineral metabolism and reduces psychiatric symptoms. Finally, we conclude that the observed beneficial effects of replacement therapy with GH are of sufficient magnitude to consider treatment of GHD adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 3,800
Lapidus, L., Bengtsson, C., Larsson, B., Pennert, K., Rybo, E., & Sjöström, L. (1984) · BMJ · doi:10.1136/bmj.289.6454.1257 · Cited by 1,660
Self-citationConfirmation of the dimensional structure of the scl-90: A study in construct validation
Derogatis, L. R., & Cleary, P. A. (1977) · Journal of Clinical Psychology · doi:10.1002/1097-4679(197710)33:4<981::aid-jclp2270330412>3.0.co;2-0 · Cited by 1,563
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Self-citationSalomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Kvist, H., Chowdhury, B., Grangård, U., Tylén, U., & Sjöström, L. (1988) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/48.6.1351 · Cited by 794
Self-citationGrowth Hormone Stimulates Longitudinal Bone Growth Directly
Isaksson, O. G. P., Jansson, J.-O., & Gause, I. A. M. (1982) · Science · doi:10.1126/science.7079756 · Cited by 525
Self-citationAdipose tissue volume determinations in women by computed tomography: technical considerations.
Kvist, H., Sjöström, L., & Tylén, U. (1986) · PubMed · Cited by 377
Self-citationEffects of Short Term Administration of Recombinant Human Growth Hormone to Elderly People*
MARCUS, R., BUTTERFIELD, G., HOLLOWAY, L., GILLILAND, L., BAYLINK, D. J., HINTZ, R. L., & SHERMAN, B. M. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-519 · Cited by 282
Cited by
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Ohlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., & Slootweg, M. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0324 · Cited by 855
Self-citationGrowth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationSACCÀ, L., CITTADINI, A., & FAZIO, S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-555 · Cited by 543
Body fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
Kelly, D. F., Gaw Gonzalo, I. T., Cohan, P., Berman, N., Swerdloff, R., & Wang, C. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.93.5.0743 · Cited by 455
Amato, G. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1671 · Cited by 440
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., Shalet, S. M., Vance, M. L., & for The Endocrine Society’s Clinical Guidelines Subcommittee (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2227 · Cited by 424
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414
Diagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
Systematic review: the safety and efficacy of growth hormone in the healthy elderly
Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00005 · Cited by 370
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344
Landin‐Wllhelmsen, K., Wllhelmsen, L., Lappast, G., Rosen, T., Lindstedt, G., Lundberg, P., & Bengtsson, B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02556.x · Cited by 340
Self-citationCardiovascular risk factors in adult patients with growth hormone deficiency
Rosén, T., Edén, S., Larson, G., Wilhelmsen, L., & Bengtsson, B.-Å. (1993) · Acta Endocrinologica · doi:10.1530/acta.0.1290195 · Cited by 338
Self-citationJohannsson, G., Mårin, P., Lönn, L., Ottosson, M., Stenlöf, K., Björntorp, P., Sjöström, L., & Bengtsson, B.-Å. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3809 · Cited by 335
Self-citationCurrent and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 331
The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients
Gibney, J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2596 · Cited by 324
Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus
Björntorp, P., Holm, G., & Rosmond, R. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00067.x · Cited by 322
Decreased psychological well‐being in adult patients with growth hormone deficiency
Rosén, T., Wirén, L., Wilhelmsen, L., Wiklund, I., & Bengtsson, B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02452.x · Cited by 316
Self-citationYuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Growth Hormone (GH)-Deficient Men Are More Responsive to GH Replacement Therapy Than Women1
Burman, P., Johansson, A. G., Siegbahn, A., Vessby, B., & Karlsson, F. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3776 · Cited by 295
Sarcopenia—consequences, mechanisms, and potential therapies
Greenlund, L. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00196-3 · Cited by 294
Burman, P. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3585 · Cited by 290
Weaver, J. U. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.153 · Cited by 282
Baum, H. B. A., Biller, B. M. K., Finkelstein, J. S., Cannistraro, K. B., Oppenheim, D. S., Schoenfeld, D. A., Michel, T. H., Wittink, H., & Klibanski, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-11-199612010-00003 · Cited by 277
Böger, R. H., Skamira, C., Bode-Böger, S. M., Brabant, G., von zur Muhlen, A., & Frolich, J. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119095 · Cited by 270
Comparing adiposity profiles in three mouse models with altered GH signaling
Berryman, D. E., List, E. O., Coschigano, K. T., Behar, K., Kim, J. K., & Kopchick, J. J. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.02.005 · Cited by 269
Growth Hormone Therapy in Adults and Children
Vance, M. L., & Mauras, N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411607 · Cited by 269
Higham, C. E., Johannsson, G., & Shalet, S. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30053-8 · Cited by 267
Abs, R., Bengtsson, B., Hernberg‐Ståhl, E., Monson, J. P., Tauber, J., Wilton, P., & Wüster, C. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00695.x · Cited by 267
Self-citationMcKenna, S. P., Doward, L. C., Alonso, J., Kohlmann, T., Niero, M., Prieto, L., & Wíren, L. (1999) · Quality of Life Research · doi:10.1023/a:1008987922774 · Cited by 263
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257
Johannsson, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2865 · Cited by 258
Nass, R., Pezzoli, S. S., Oliveri, M. C., Patrie, J. T., Harrell, F. E., Clasey, J. L., Heymsfield, S. B., Bach, M. A., Vance, M. L., & Thorner, M. O. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00003 · Cited by 255
Abdominal Obesity and the Metabolic Syndrome
Björntorp, P. (1992) · Annals of Medicine · doi:10.3109/07853899209166997 · Cited by 233
Hoffman, A. R., Kuntze, J. E., Baptista, J., Baum, H. B. A., Baumann, G. P., Biller, B. M. K., Clark, R. V., Cook, D., Inzucchi, S. E., Kleinberg, D., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030346 · Cited by 185
Effect of growth hormone replacement therapy on cognition after traumatic brain injury
High, W. M., Briones-Galang, M., Clark, J. A., Gilkison, C., Mossberg, K. A., Zgaljardic, D. J., Masel, B. E., & Urban, R. J. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1253 · Cited by 176
Kelly, D. F., McArthur, D. L., Levin, H., Swimmer, S., Dusick, J. R., Cohan, P., Wang, C., & Swerdloff, R. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.928 · Cited by 158
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism
Tanriverdi, F., Unluhizarci, K., Coksevim, B., Selcuklu, A., Casanueva, F. F., & Kelestimur, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02737.x · Cited by 130
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency
Evans, M., Davies, Goodfellow, Rees, & Scanlon (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00671.x · Cited by 129
Kelly, D. F., Chaloner, C., Evans, D., Mathews, A., Cohan, P., Wang, C., Swerdloff, R., Sim, M.-S., Lee, J., Wright, M. J., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3212 · Cited by 101
Which adults develop side-effects of growth hormone replacement?
Holmes, S. J., & Shalet, S. M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01908.x · Cited by 101
Beauregard, C., Utz, A. L., Schaub, A. E., Nachtigall, L., Biller, B. M. K., Miller, K. K., & Klibanski, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2371 · Cited by 99
Growth hormone replacement therapy in patients with traumatic brain injury
Moreau, O. K., Cortet-Rudelli, C., Yollin, E., Merlen, E., Daveluy, W., & Rousseaux, M. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2705 · Cited by 94
Le Grevès, M., Zhou, Q., Berg, M., Le Grevès, P., Fhölenhag, K., Meyerson, B., & Nyberg, F. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0438-2 · Cited by 92
Klose, M., Watt, T., Brennum, J., & Feldt-Rasmussen, U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0901 · Cited by 87
Radiation-induced hypopituitarism
Fernandez, A., Brada, M., Zabuliene, L., Karavitaki, N., & Wass, J. A. H. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0231 · Cited by 84
Drake, W. M., Rodríguez‐Arnao, J., Weaver, J. U., James, I. T., Coyte, D., Spector, T. D., Besser, G. M., & Monson, J. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01246.x · Cited by 76
Arce, V. M., Devesa, P., & Devesa, J. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.03.014 · Cited by 70
Anderson, L. J., Tamayose, J. M., & Garcia, J. M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.010 · Cited by 70
Hypothalamic mTORC2 is essential for metabolic health and longevity
Chellappa, K., Brinkman, J. A., Mukherjee, S., Morrison, M., Alotaibi, M. I., Carbajal, K. A., Alhadeff, A. L., Perron, I. J., Yao, R., Purdy, C. S., et al. (2019) · Aging Cell · doi:10.1111/acel.13014 · Cited by 62
Impact of the GH-cortisol ratio on the age-dependent changes in body composition
Nass, R., & Thorner, M. O. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00022-9 · Cited by 58
Leonsson, M., Hulthe, J., Oscarsson, J., Johannsson, G., Wendelhag, I., Wikstrand, J., & Bengtsson, B. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01663.x · Cited by 49
Self-citationValk, N. K., Erdtsieck, R. J., Algra, D., Lamberts, S. W. J., & Pols, H. A. P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02038.x · Cited by 28
Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism
Bengtsson, B.-Å. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80014-2 · Cited by 22
Self-citationTanriverdi, F., Karaca, Z., Unluhizarci, K., & Kelestimur, F. (2014) · Endocrine · doi:10.1007/s12020-014-0276-0 · Cited by 20
Attallah, H., Friedlander, A. L., Nino-Murcia, M., & Hoffman, A. R. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020021 · Cited by 19
Holmer, H., Svensson, J., Rylander, L., Johannsson, G., Rosén, T., Bengtsson, B.-Å., Thorén, M., Höybye, C., Degerblad, M., Bramnert, M., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.008 · Cited by 16
“Clinically, improvements in QoL have been demonstrated during GH replacement therapy in most (Bengtsson et al., 1993; Burman et al., 1995; Rosilio et al., 2004), but not all (Baum et al.”
BackgroundSelf-citation
Metadata
- Authors
- Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1993-02
- Volume
- 76
- Issue
- 2
- Pages
- 309-317
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2054229227
- Cited by
- 778
- References
- 34
- FWCI
- 31.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.